Correlation Between Adial Pharmaceuticals and Bio Path
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Bio Path Holdings, you can compare the effects of market volatilities on Adial Pharmaceuticals and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Bio Path.
Diversification Opportunities for Adial Pharmaceuticals and Bio Path
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Adial and Bio is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Bio Path go up and down completely randomly.
Pair Corralation between Adial Pharmaceuticals and Bio Path
Given the investment horizon of 90 days Adial Pharmaceuticals is expected to generate 0.91 times more return on investment than Bio Path. However, Adial Pharmaceuticals is 1.09 times less risky than Bio Path. It trades about -0.3 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.41 per unit of risk. If you would invest 106.00 in Adial Pharmaceuticals on November 3, 2024 and sell it today you would lose (23.00) from holding Adial Pharmaceuticals or give up 21.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Adial Pharmaceuticals vs. Bio Path Holdings
Performance |
| Timeline |
| Adial Pharmaceuticals |
| Bio Path Holdings |
Adial Pharmaceuticals and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adial Pharmaceuticals and Bio Path
The main advantage of trading using opposite Adial Pharmaceuticals and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |